Fidelity Investments
AGN

Fidelity Investments’s Allergan plc AGN Stock Holding History

Fidelity Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-936,522
Closed -$166M – 4443
2020
Q1 		$166M Sell
936,522
-849,781
-48% -$160M 0.02% 571
2019
Q4 		$341M Sell
1,786,303
-322,141
-15% -$58.1M 0.04% 433
2019
Q3 		$355M Sell
2,108,444
-3,721,713
-64% -$606M 0.04% 414
2019
Q2 		$976M Sell
5,830,157
-211,848
-4% -$29.3M 0.11% 174
2019
Q1 		$885M Buy
6,042,005
+1,788,265
+42% +$259M 0.11% 180
2018
Q4 		$569M Buy
4,253,740
+245,322
+6% +$40.2M 0.08% 248
2018
Q3 		$764M Sell
4,008,418
-1,876,150
-32% -$345M 0.09% 213
2018
Q2 		$981M Sell
5,884,568
-2,045,965
-26% -$328M 0.11% 171
2018
Q1 		$1.33B Sell
7,930,533
-2,050,622
-21% -$344M 0.16% 130
2017
Q4 		$1.63B Sell
9,981,155
-3,896,353
-28% -$699M 0.19% 99
2017
Q3 		$2.84B Buy
13,877,508
+592,516
+4% +$138M 0.34% 48
2017
Q2 		$3.23B Sell
13,284,992
-827,201
-6% -$194M 0.4% 38
2017
Q1 		$3.37B Buy
14,112,193
+926,950
+7% +$216M 0.43% 34
2016
Q4 		$2.77B Sell
13,185,243
-1,669,009
-11% -$346M 0.37% 45
2016
Q3 		$3.42B Buy
14,854,252
+3,260,354
+28% +$797M 0.46% 36
2016
Q2 		$2.68B Sell
11,593,898
-1,898,162
-14% -$438M 0.37% 52
2016
Q1 		$3.62B Sell
13,492,060
-1,960,903
-13% -$561M 0.5% 32
2015
Q4 		$4.83B Sell
15,452,963
-677,108
-4% -$202M 0.65% 26
2015
Q3 		$4.38B Sell
16,130,071
-4,704,721
-23% -$1.45B 0.62% 24
2015
Q2 		$6.32B Sell
20,834,792
-70,494
-0.3% -$21M 0.81% 13
2015
Q1 		$6.22B Buy
20,905,286
+1,668,540
+9% +$476M 0.79% 13
2014
Q4 		$4.95B Buy
19,236,746
+803,778
+4% +$201M 0.64% 19
2014
Q3 		$4.45B Buy
18,432,968
+1,448,990
+9% +$324M 0.6% 23
2014
Q2 		$3.79B Buy
16,983,978
+330,996
+2% +$68.5M 0.51% 31
2014
Q1 		$3.43B Buy
16,652,982
+628,820
+4% +$125M 0.48% 37
2013
Q4 		$2.69B Buy
16,024,162
+4,723,912
+42% +$738M 0.38% 47
2013
Q3 		$1.63B Buy
11,300,250
+1,575,701
+16% +$210M 0.25% 78
2013
Q2 		$1.23B Buy
+9,724,549
New +$1.1B 0.2% 105

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Fidelity Investments's AGN Position: Q2 2020 in Review

Fidelity Investments sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 936,522 shares — an estimated $166M sold.

Fidelity Investments first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $6.32B in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Fidelity Investments reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Fidelity Investments sold 936,522 Allergan plc shares in Q2 2020, an estimated $166M.
  • Fidelity Investments first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Fidelity Investments's Allergan plc position peaked at $6.32B in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.